Page 1 of Clinical Trials for Drug Flovent Fluticasone HFA, 42 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
Last Updated: August 24, 2010
Condition(s): Asthma
2
Terminated
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).
Last Updated: November 16, 2011
Condition(s): Asthma
3
Terminated
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)
Last Updated: November 16, 2011
Condition(s): Asthma
4
Active, not recruiting
Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes
Last Updated: February 8, 2012
Condition(s): Asthma
5
Completed
Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients
Last Updated: June 8, 2011
Condition(s): Asthma
6
Completed
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 HFA Versus Fluticasone Propionate 100 HFA In Children With Asthma
Last Updated: August 30, 2010
Condition(s): Asthma
7
Completed
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Last Updated: July 7, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)
8
Completed
Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma
Last Updated: June 3, 2010
Condition(s): Bronchial Asthma
9
Completed
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
Last Updated: June 8, 2011
Condition(s): Asthma
10
Completed
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
Last Updated: June 8, 2011
Condition(s): Asthma
11
Terminated
Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy
Last Updated: November 16, 2011
Condition(s): Asthma
12
Completed
FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects
Last Updated: May 15, 2009
Condition(s): Asthma
13
Completed
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
Last Updated: June 8, 2011
Condition(s): Asthma
14
Completed
EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
Last Updated: October 30, 2006
Condition(s): Bronchial Asthma
15
Completed
The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry
Last Updated: November 20, 2006
Condition(s): Asthma
16
Recruiting
A Proof of Concept Study to Evaluate the Additive Effects of HFA-BDP (Qvar) to Fluticasone/Salmeterol (Seretide) on Surrogate Markers of Small and Large Airway Inflammation in Refractory Asthma
Last Updated: January 26, 2009
Condition(s): Asthma
17
Completed
Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-Week) Study-
Last Updated: June 18, 2009
Condition(s): Bronchial Asthma
18
Completed
Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma
Last Updated: August 24, 2010
Condition(s): Mild to Moderate Asthma
19
Completed
Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).
Last Updated: March 17, 2011
Condition(s): Asthma; Chronic Obstructive Airway Disease
20
Completed
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma
Last Updated: August 24, 2010
Condition(s): Asthma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Flovent+Fluticasone+HFA

Page 1 of Clinical Trials for Drug Flovent Fluticasone HFA, 42 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About